C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2011
08/25/2011	WO2011103308A2 Methods of using human protein kinase c delta viii as a biomarker
08/25/2011	WO2011103300A2 Improving activity of fe-s cluster requiring proteins
08/25/2011	WO2011103248A2 AXMI221z, AXMI222z, AXMI223z, AXMI224z, AND AXMI225z DELTA-ENDOTOXIN GENES AND METHODS FOR THEIR USE
08/25/2011	WO2011103247A2 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use
08/25/2011	WO2011103242A1 Neuregulin antagonists and use thereof in treating cancer
08/25/2011	WO2011103236A2 Personalized tumor biomarkers
08/25/2011	WO2011103163A2 Nucleic acid extraction from complex matrices
08/25/2011	WO2011103159A2 Assay for detecting closely- related serotypes of human papillomavirus (hpv)
08/25/2011	WO2011103154A2 A green tissue-preferred promoter from maize
08/25/2011	WO2011103105A1 Fibronectin based scaffold domain proteins that bind il-23
08/25/2011	WO2011103011A2 Gene fusion targeted therapy
08/25/2011	WO2011102933A1 Amylase from nesterenkonia and methods of use, thereof
08/25/2011	WO2011102900A1 Universal virus-like particle (vlp) influenza vaccines
08/25/2011	WO2011102860A1 Rage fusion protein compositions and methods of use
08/25/2011	WO2011102847A1 Compositions and methods for treatment of parkinson's disease
08/25/2011	WO2011102802A1 Method for reducing mismatches in double-stranded dna molecules
08/25/2011	WO2011102580A2 Liver cancer prognosis method and kit using a genomic quantitative pcr
08/25/2011	WO2011102556A1 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102555A1 Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102554A1 Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102553A1 Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102552A1 Antibody against a band lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102551A1 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa
08/25/2011	WO2011102532A1 Induced hepatocytes
08/25/2011	WO2011102517A1 Antiviral agent, abzyme, primer set, method for producing polynucleotide, and method for producing polypeptide
08/25/2011	WO2011102507A1 Method for identification of oncogene, method for establishment of cell capable of expressing oncogene, and method for screening for oncogene-targeting substance
08/25/2011	WO2011102483A1 HUMAN LAP TGF-β BINDING ANTIBODY
08/25/2011	WO2011102476A1 Method for detecting atherosclerotic diseases on the basis of single nucleotide polymorphism at human chromosome 5p15.3
08/25/2011	WO2011102461A1 Protein expressed specifically in ovarian clear cell adenocarcinoma and use applications thereof
08/25/2011	WO2011102444A1 Method for producing induced pluripotent stem cells
08/25/2011	WO2011102414A1 Oligonucleotide derivative
08/25/2011	WO2011102394A1 Plant component regulation factor, and use thereof
08/25/2011	WO2011102388A1 Method for producing 1-amino-1-alkoxycarbonyl-2-vinylcyclopropane
08/25/2011	WO2011102342A1 Antibody-immobilized carrier, method of producing antibody-immobilized carrier, and use of said antibody-immobilized carrier
08/25/2011	WO2011102301A1 Novel promoter for use in transformation of algae
08/25/2011	WO2011102178A1 Analysis system using modified reporter gene
08/25/2011	WO2011101912A1 Recombinant herpes virus and pharmaceutical composition containing recombinant herpes virus
08/25/2011	WO2011101870A1 Fusion proteins for the treatment of multiple sclerosis and other autoimmune diseases
08/25/2011	WO2011101869A1 Adeno-associated virus 2/8 - micro rna-101 therapy for liver cancer
08/25/2011	WO2011101811A2 Improved meganuclease recombination system
08/25/2011	WO2011101696A1 Improved meganuclease recombination system
08/25/2011	WO2011101472A2 Complexes of an3-interacting proteins and their use for plant growth promotion
08/25/2011	WO2011101332A1 Compositions based on the fibronectin extracellular domain a for the treatment of melanoma
08/25/2011	WO2011100982A2 SUPPRESSORS OF RNA SILENCING AS MODULATORS OF miRNA LEVELS
08/25/2011	WO2011082325A3 Sequences of e.coli 055:h7 genome
08/25/2011	WO2011080329A3 Gpav gene resistant to nematodes in the nightshade family
08/25/2011	WO2011075004A9 Anti-thrombosis aptamers and method for stabilizing the structure thereof
08/25/2011	WO2011064668A3 Plants that reproduce via unreduced gametes
08/25/2011	WO2011052883A3 Method for activating a natural killer cell by adjusting the expression of the socs2 gene
08/25/2011	WO2011044133A3 High affinity adaptor molecules for redirecting antibody specifity
08/25/2011	WO2011026912A3 Retinoic acid receptor antagonists, mir-10a inhibitors and inhibitors of hoxb1 or hoxb3 repressors for treating pancreatic cancer
08/25/2011	WO2011025344A3 Attenuated salmonella mutants wherein adhesin of bovine pathogenic escherichia coli is transformed, and vaccine composition for preventing and treating bovine colibacillosis and salmonellosis comprising same
08/25/2011	WO2011025242A3 Dna fragment for improving translation efficiency, and recombinant vector containing same
08/25/2011	WO2011025203A3 Novel preparation method of human metabolites of simvastatin or lovastatin using bacterial cytochrome p450 and composition therefor
08/25/2011	WO2011008058A3 Method for producing fatty acid alkyl esters using microorganisms having oil-producing ability
08/25/2011	WO2011003822A3 Aqueous insulin preparations containing methionine
08/25/2011	WO2010148203A3 Producer cells for replication competent retroviral vectors
08/25/2011	WO2010142660A3 Microparticles comprising sirna
08/25/2011	US20110209251 Method for promoting efficiency of gene introduction into plant cells
08/25/2011	US20110209250 Methods and compositions for plant improvement
08/25/2011	US20110209249 Plants having improved growth characteristics and a method for making the same
08/25/2011	US20110209248 Novel sugar transporters
08/25/2011	US20110209247 Transgenic Plant Having Enhanced Drought Tolerance
08/25/2011	US20110209246 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
08/25/2011	US20110209244 Method for production of plant imparted with stress tolerance and use thereof
08/25/2011	US20110209243 Salinity tolerance in plants
08/25/2011	US20110209242 Green Tissue-Preferred Promoter from Maize
08/25/2011	US20110209241 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
08/25/2011	US20110209240 Hybrid tomato ps01544291 and parent lines thereof
08/25/2011	US20110209239 Tomato hybrid ps01533588
08/25/2011	US20110209238 Cotton variety 09r619b2r2
08/25/2011	US20110209237 Cotton variety 09r555b2r2
08/25/2011	US20110209236 Cotton variety 09r550b2r2
08/25/2011	US20110209235 Cotton variety 09r549b2r2
08/25/2011	US20110209234 Cotton variety 09r796b2r2
08/25/2011	US20110209232 Herbicide-resistant sunflower plants, polynucleotides encoding herbicide-resistant acetohydroxyacid synthase large subunit proteins, and methods of use
08/25/2011	US20110209231 Treatment and prevention of influenza
08/25/2011	US20110209230 Human Monoclonal Antibodies To Programmed Death Ligand 1 (PD-L1)
08/25/2011	US20110209229 Gene of porcine beta casein, a promoter of the same and the use thereof
08/25/2011	US20110209228 Method of treatment using antimicrobial composition
08/25/2011	US20110209227 Methods for the diagnosis and treatment of bone disorders
08/25/2011	US20110208673 Antibodies to lymphotoxin-alpha
08/25/2011	US20110207985 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
08/25/2011	US20110207912 Fgf-19 nucleic acids
08/25/2011	US20110207911 Polypeptide derived from the ryanodine receptor that inhibits calcium leakage
08/25/2011	US20110207802 Glutamic acid decarboxylase (gad) based delivery system
08/25/2011	US20110207801 Novel Genes, Compositions, and Methods for Modulating the Unfolded Protein Response
08/25/2011	US20110207797 Enhanced antisense oligonucleotides
08/25/2011	US20110207795 Smad7 inhibitor compositions and uses thereof
08/25/2011	US20110207775 Agent that modulates physiological condition of pests, involved in insect vesicle-fusing atpase activity
08/25/2011	US20110207707 Compounds That Act To Modulate Insect Growth And Methods And Systems For Identifying Such Compounds
08/25/2011	US20110207705 Oviedomycin derivatives, method for obtaining same and use thereof
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207677 Use of Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Digestive Diseases
08/25/2011	US20110207669 Recombinant proteins having haemostatic activity and capable of inducing platelet aggregation
08/25/2011	US20110207664 Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor DNAs and Proteins
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110207628 Open-reading-frame (orf) phage display
08/25/2011	US20110207625 Pirna and uses related thereto
08/25/2011	US20110207623 Methods for detection and quantification of analytes in complex mixtures

1 ... 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 ... 4023